Remission outcomes in severe eosinophilic asthma with mepolizumab therapy: Analysis of the REDES study

Remission outcomes in severe eosinophilic asthma with mepolizumab therapy: Analysis of the REDES study

IntroductionClinical remission as a multicomponent treatment goal in severe asthma is being explored in clinical practice. This post hoc analysis used data from the REDES study to assess the proportion of patients with severe eosinophilic asthma achieving our multicomponent definitions of clinical r...

תיאור מלא

מידע ביבליוגרפי
Main Authors:	Ian Pavord, Frances Gardiner, Liam G. Heaney, Christian Domingo, Robert G. Price, Alison Pullan, John Oppenheimer, Guy Brusselle, Hiroyuki Nagase, Geoffrey Chupp, Emilio Pizzichini, David Bañas-Conejero, Peter Howarth
פורמט:	Article
שפה:	English
יצא לאור:	Frontiers Media S.A. 2023-04-01
סדרה:	Frontiers in Immunology
נושאים:	severe asthma remission clinical outcomes real-world eosinophil biology mepolizumab
גישה מקוונת:	https://www.frontiersin.org/articles/10.3389/fimmu.2023.1150162/full

פריטים דומים

A Case of Eosinophilic Gastroenteritis Remission Achieved Steroid-Free With Mepolizumab
מאת: Yuki Hirata, et al.
יצא לאור: (2022-01-01)

Safety and effectiveness of mepolizumab therapy in remission induction therapy for eosinophilic granulomatosis with polyangiitis: a retrospective study
מאת: Masanobu Ueno, et al.
יצא לאור: (2022-06-01)

Mepolizumab in the treatment of eosinophilic chronic obstructive pulmonary disease
מאת: Mkorombindo T, et al.
יצא לאור: (2019-08-01)

Evaluation of Clinical Remission in Best-Performing Severe Asthmatic Patients Treated for Three Years with Mepolizumab
מאת: Diego Bagnasco, et al.
יצא לאור: (2024-04-01)

Efficacy of add-on mepolizumab in adolescents with severe eosinophilic asthma
מאת: Steven W. Yancey, et al.
יצא לאור: (2019-09-01)

Patient profiles and clinical utility of mepolizumab in severe eosinophilic asthma
מאת: Haldar P
יצא לאור: (2017-06-01)

Mepolizumab-responsive recurrent eosinophilic eruption without peripheral eosinophilia
מאת: Nina B. Curkovic, MD, et al.
יצא לאור: (2024-11-01)

The clinical question of mepolizumab in the long-term treatment of idiopathic chronic eosinophilic pneumonia; how long should we use mepolizumab?
מאת: Masamitsu Hamakawa, et al.
יצא לאור: (2024-01-01)

Effectiveness and safety of mepolizumab in combination with corticosteroids in patients with eosinophilic granulomatosis with polyangiitis
מאת: Masanobu Ueno, et al.
יצא לאור: (2021-03-01)

Effectiveness of mepolizumab for eosinophilic pneumonia following bronchial thermoplasty
מאת: Ryota Otoshi, et al.
יצא לאור: (2020-03-01)

Clinical efficacy of mepolizumab in the treatment of severe eosinophilic asthma in children
מאת: V. N. Drozdov, et al.
יצא לאור: (2020-11-01)

Real-life efficacy and safety of mepolizumab for eosinophilic granulomatosis with polyangiitis
מאת: Giuseppe A. Ramirez, et al.
יצא לאור: (2022-12-01)

Severe eosinophilic asthma: from the pathogenic role of interleukin-5 to the therapeutic action of mepolizumab
מאת: Pelaia C, et al.
יצא לאור: (2017-10-01)

May mepolizumab used in asthma correct subfertility?
מאת: Guzin Ozden, et al.
יצא לאור: (2021-01-01)

Allergic bronchopulmonary aspergillosis complicated by eosinophilic chronic rhinosinusitis successfully treated with mepolizumab
מאת: Nobuhiro Matsumoto, et al.
יצא לאור: (2019-10-01)

Experience with mepolizumab in adults with severe eosinophilic asthma: a case series from India
מאת: Venkata Nagarjuna Maturu, et al.
יצא לאור: (2021-08-01)

Efficacy of mepolizumab for patients with severe asthma and eosinophilic chronic rhinosinusitis
מאת: Takanori Numata, et al.
יצא לאור: (2019-10-01)

Clinical Remission Criteria and Serum Levels of Type 2 Inflammation Mediators during 24 Weeks of Treatment with the Anti-IL-5 Drug Mepolizumab in Patients with T2-High Severe Asthma
מאת: Jolita Palacionyte, et al.
יצא לאור: (2024-06-01)

Mepolizumab asthma treatment failure due to refractory airway eosinophilia, which responded to benralizumab
מאת: Alistair Cook, et al.
יצא לאור: (2021-05-01)

Predictors of the enhanced response to mepolizumab treatment for severe eosinophilic asthma: A retrospective, long-term study
מאת: Takanori Numata, et al.
יצא לאור: (2020-01-01)

Real-world outcomes of mepolizumab for the treatment of severe eosinophilic asthma in Canada: an observational study
מאת: Kenneth R. Chapman, et al.
יצא לאור: (2024-02-01)

Response to case report: Airway autoimmune responses in severe eosinophilic asthma following low-dose Mepolizumab therapy
מאת: I. J. Pouliquen, et al.
יצא לאור: (2017-11-01)

Mepolizumab para el tratamiento de asma grave eosinofílica
מאת: Armando Partida-Gaytán, et al.
יצא לאור: (2021-01-01)

When sequential use of mepolizumab and dupilumab in a severe atopic eosinophilic asthmatic questions the role of eosinophils in mediating the clinical expression of the disease: a case report
מאת: M. Sabbe, et al.
יצא לאור: (2024-01-01)

Mepolizumab exerts crucial effects on glucocorticoid discontinuation in patients with eosinophilic granulomatosis with polyangiitis: a retrospective study of 27 cases at a single center in Japan
מאת: Takashi Yamane, et al.
יצא לאור: (2023-06-01)

Mepolizumab Therapy for Recalcitrant Eosinophilic Annular Erythema in an Adult: A Case Report and Review of Treatment Options
מאת: Magdalena Żychowska, et al.
יצא לאור: (2020-06-01)

Case Report: Mepolizumab in the treatment of idiopathic chronic eosinophilic pneumonia [version 3; peer review: 2 approved]
מאת: Moetemri Zied, et al.
יצא לאור: (2023-09-01)

Real-world outcomes of mepolizumab treatment in severe eosinophilic asthma patients - retrospective cohort study in Slovakia
מאת: Milos Jesenak, et al.
יצא לאור: (2023-09-01)

Idiopathic hypereosinophilic syndrome with eosinophilic cellulitis-like cutaneous involvement treated with mepolizumab and dapsone
מאת: Madeleine Lachance, MD, et al.
יצא לאור: (2022-04-01)

Combination effect of Mepolizumab and Endobronchial Watanabe Spigot (EWS) in drug‐induced eosinophilic pneumonia complicated by refractory pneumothorax
מאת: Nana Ayame, et al.
יצא לאור: (2024-09-01)

Switching from omalizumab to mepolizumab therapy improved extra‐pulmonary abdominal and cutaneous vasculitis symptoms in a patient with eosinophilic granulomatosis with polyangiitis
מאת: Yu‐Hsuan Chen, et al.
יצא לאור: (2022-01-01)

Role of mepolizumab in severe allergic asthma with vocal cord polyp
מאת: Azmat Karim, et al.
יצא לאור: (2022-01-01)

Very long-term data on patients with severe eosinophilic asthma treated with mepolizumab: a case series
מאת: Carlo Lombardi, et al.
יצא לאור: (2024-07-01)

Mepolizumab improves clinical outcomes in patients with severe asthma and comorbid conditions
מאת: Peter G. Gibson, et al.
יצא לאור: (2021-06-01)

Severe asthma remaining well‐controlled after mepolizumab discontinuation: A case report and literature review
מאת: Takahiro Matsuyama, et al.
יצא לאור: (2023-06-01)

Long-term mepolizumab treatment reduces relapse rates in super-responders with eosinophilic granulomatosis with polyangiitis
מאת: Nami Masumoto, et al.
יצא לאור: (2023-05-01)

Severe eosinophilic bronchial asthma: new therapeutic options
מאת: N. M. Nenasheva
יצא לאור: (2018-10-01)

Low-dose anti-IL 5 treatment in idiopathic hypereosinophilic syndrome: towards a precision medicine approach for remission maintenance
מאת: Marco Caminati, et al.
יצא לאור: (2023-09-01)

Gastrointestinal Involvement of Eosinophilic Granulomatosis with Polyangiitis with Histological Evidence of Treatment Response
מאת: Mark Lai, et al.
יצא לאור: (2023-03-01)

Economic evaluation and budgetary burden of mepolizumab in severe refractory eosinophilic asthma
מאת: Manuel David Gil-Sierra, et al.
יצא לאור: (2019-11-01)